SCHEMBL9914923

SCHEMBL9914923

C=C(C)/N=C\N(N)c1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)CCC4CCCC4)CC3)c[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.43
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
KCNH2 Q12809 1/20 0.39
ALDH1A1 P00352 7/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.32
ATM Q13315 2/20 0.32
HSD11B1 P28845 1/20 0.32
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
ACHE P22303 1/20 0.30
HTR4 Q13639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9914927 0.88 CYP2C9 (0.45) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL9914931 0.87 CYP2C9 (0.47) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12101652 0.77 CYP2C9 (0.39) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL15273586 0.77 CYP3A4 (0.66) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12101629 0.77 CYP2C9 (0.36) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL15273634 0.76 CYP3A4 (0.67) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL14385656 0.76 CYP2C9 (0.48) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL12513521 0.76 CYP2C9 (0.45) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL9914925 0.75 CYP2C9 (0.47) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6
SCHEMBL9914946 0.75 CYP2C9 (0.47) CYP2C9CYP3A4CYP1A2CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012075235-A1 ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-06-07 WO disclosed